Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103


P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells.

Yan DH, Abramian A, Li Z, Ding Y, Wen Y, Liu TJ, Hunt K.

Biochem Biophys Res Commun. 2003 Mar 28;303(1):219-22.


Inhibition of E2F-4/DP-1-stimulated transcription by p202.

Choubey D, Gutterman JU.

Oncogene. 1997 Jul 17;15(3):291-301.


p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein.

Xin H, D'Souza S, Fang L, Lengyel P, Choubey D.

Oncogene. 2001 Oct 18;20(47):6828-39.


Inhibition of E2F-mediated transcription by p202.

Choubey D, Li SJ, Datta B, Gutterman JU, Lengyel P.

EMBO J. 1996 Oct 15;15(20):5668-78.


Prostate-specific antitumor activity by probasin promoter-directed p202 expression.

Wen Y, Giri D, Yan DH, Spohn B, Zinner RG, Xia W, Thompson TC, Matusik RJ, Hung MC.

Mol Carcinog. 2003 Jul;37(3):130-7.


Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.

Yang HL, Dong YB, Elliott MJ, Liu TJ, Atienza C Jr, Stilwell A, McMasters KM.

Clin Cancer Res. 1999 Aug;5(8):2242-50.


Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer.

Ding Y, Wen Y, Spohn B, Wang L, Xia W, Kwong KY, Shao R, Li Z, Hortobagyi GN, Hung MC, Yan DH.

Clin Cancer Res. 2002 Oct;8(10):3290-7.


p202 prevents apoptosis in murine AKR-2B fibroblasts.

Koul D, Lapushin R, Xu HJ, Mills GB, Gutterman JU, Choubey D.

Biochem Biophys Res Commun. 1998 Jun 18;247(2):379-82.


Roles of E2F1 in mesangial cell proliferation in vitro.

Inoshita S, Terada Y, Nakashima O, Kuwahara M, Sasaki S, Marumo F.

Kidney Int. 1999 Dec;56(6):2085-95.


Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.

Itoshima T, Fujiwara T, Waku T, Shao J, Kataoka M, Yarbrough WG, Liu TJ, Roth JA, Tanaka N, Kodama M.

Clin Cancer Res. 2000 Jul;6(7):2851-9.


The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1.

Fortin A, MacLaurin JG, Arbour N, Cregan SP, Kushwaha N, Callaghan SM, Park DS, Albert PR, Slack RS.

J Biol Chem. 2004 Jul 2;279(27):28706-14. Epub 2004 Apr 22.


Apaf-1 is a mediator of E2F-1-induced apoptosis.

Furukawa Y, Nishimura N, Furukawa Y, Satoh M, Endo H, Iwase S, Yamada H, Matsuda M, Kano Y, Nakamura M.

J Biol Chem. 2002 Oct 18;277(42):39760-8. Epub 2002 Jul 30.


E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3.

Giovanni A, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, Robertson GS, Slack RS, Park DS.

J Biol Chem. 2000 Apr 21;275(16):11553-60.


Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells.

Nguyen KH, Hachem P, Khor LY, Salem N, Hunt KK, Calkins PR, Pollack A.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):238-46.


The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation.

Hou ST, Cowan E, Walker T, Ohan N, Dove M, Rasqinha I, MacManus JP.

J Neurochem. 2001 Jul;78(2):287-97.

Supplemental Content

Support Center